Abstract:Introduction: In the United States, e-cigarettes have entered a new regulatory era, needing authorizations from FDA to remain on or enter the marketplace. This study explored the impact of e-cigarette authorization messages on product perceptions and interest. Methods: We conducted an online experiment in June 2022 with nationally-representative samples of adults (21+) who smoke cigarettes (n=866) and youth ages 15-20 (n=859). They were randomized to one of five conditions: viewing an ad for a fictional e-cigarette brand with no reference to FDA (control), an ad with an "authorized for sale by FDA" claim in varying presentation styles (plain text, FDA "approved" stamp, FDA logo), or reading a fictional news excerpt about the product's authorization plus control ad. We compared group differences on product interest, susceptibility, harm perceptions and message perceptions. Results: Among adults who smoke, there were no effects on product interest nor susceptibility, but ratings of the product's harmfulness compared to cigarettes were lower among those in the news versus control condition (β=-0.25, p=.04). Among youth, odds of susceptibility were higher among ever e-cigarette users who viewed the ad with the FDA logo authorization message relative to the control ad (OR=6.3, 95% CI:1.67-23.9, p<0.01). About 40% of all participants agreed the authorization claim makes them think the product is safe to use, but fewer (14-19%) agreed it makes them more interested in trying it. Conclusions: FDA e-cigarette authorization messages may impact some beliefs about product harm. More research is needed to track potential impacts on product use. Implications: This study provides new data about the potential impact of messages about FDA authorization of e-cigarette products (presented as ad claims or a news story) on authorized product perceptions, interest and susceptibility among adults who smoke cigarettes and youth. Our results suggest that FDA e-cigarette authorization messages may impact harm-related beliefs among adults who smoke and product susceptibility among youth who have ever used e-cigarettes before, though real-world effects are likely to be impacted by message type and format, and perceived message source and credibility. Authorization messages are likely to be misinterpreted as "FDA approval" by some; therefore, providing clarifications about authorization meaning and standards are relevant where possible.

Communicating Risk Differences Between Electronic and Combusted Cigarettes: the Role of the FDA-mandated Addiction Warning and a Nicotine Fact Sheet

Testing messages about comparative risk of electronic cigarettes and combusted cigarettes.

'The lesser devil you don't know': a qualitative study of smokers' responses to messages communicating comparative risk of electronic and combusted cigarettes.

Independent and combined effects of very low nicotine cigarette messages and e-cigarette messages: a randomised clinical trial

Feeling Hopeful Motivates Change: Emotional Responses To Messages Communicating Comparative Risk Of Electronic Cigarettes And Combusted Cigarettes

Will E-Cigarette Modified Risk Messages with a Nicotine Warning Polarize Smokers' Beliefs about the Efficacy of Switching Completely to E-Cigarettes in Reducing Smoking-Related Risks?

Effects Of A Nicotine Fact Sheet On Perceived Risk Of Nicotine And E-Cigarettes And Intentions To Seek Information About And Use E-Cigarettes

Managing a policy paradox? Responses to textual warning labels on E-cigarette advertisements among U.S. national samples of youth overall and adults who smoke or vape

Psychological distress and responses to comparative risk messages about electronic and combusted cigarettes.

Contingent Effects of E-Cigarette Warning Label Messages on Cognitive Elaboration and Fear Among U.S. Youth Ages 14–17 by Vaping Experience and Peer Vaping Behavior

US adolescents' response to nicotine warning labels in influencer e-cigarette marketing social media posts: a survey-based randomised between-subject experiment

The Dilemma of Correcting Nicotine Misperceptions: Nicotine Replacement Therapy versus Electronic Cigarettes

Correcting misperceptions about very low nicotine cigarettes for cigarette-only smokers, dual/poly smokers, other tobacco users, and non-tobacco users

Targeted Versus Nontargeted Communication About Electronic Nicotine Delivery Systems In Three Smoker Groups

Effects of Framing Nicotine Reduction in Cigarettes on Anticipated Tobacco Product Use Intentions and Risk Perceptions Among US Adult Smokers.

Reactions to Messages about a Nicotine Reduction Policy: A Focus Group Study among People Who Use Little Cigars and Cigarillos

Randomised experiment for the effect of ‘Tobacco-Free Nicotine’ messaging on current e-cigarette users’ perceptions, preferences and intentions

Perceived Risk Of Electronic Cigarettes Compared With Combustible Cigarettes: Direct Versus Indirect Questioning

Messaging about Very Low Nicotine Cigarettes (vlncs) to Influence Policy Attitudes, Harm Perceptions and Smoking Motivations: a Discrete Choice Experiment

The impact of exposure to FDA e-cigarette authorization messages on product perceptions and interest - an experiment with adults who smoke and youth

Effects of reduced nicotine content cigarette advertising with warning labels and social media features on product perceptions among young adults